Form 8-K - Current report:
SEC Accession No. 0001628280-21-011892
Filing Date
2021-06-10
Accepted
2021-06-09 20:55:39
Documents
12
Period of Report
2021-06-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nautilus-form8xkclosing.htm 8-K 389831
2 EX-3.1 exhibit31-form8xkclosing.htm EX-3.1 36450
3 EX-3.2 exhibit32-form8xkclosing.htm EX-3.2 235791
4 EX-4.1 exhibit41-super8xkclosing.htm EX-4.1 4967
5 EX-10.4 exhibit104-form8xkclosing.htm EX-10.4 153786
6 EX-10.5 exhibit105-form8xkclosing.htm EX-10.5 165567
7 EX-16.1 exhibit161-super8xk.htm EX-16.1 3487
8 EX-99.1 exhibit991-super8xkfinanci.htm EX-99.1 434361
9 EX-99.2 exhibit992-super8xknautilu.htm EX-99.2 224916
10 EX-99.3 exhibit993-super8xk.htm EX-99.3 16027
11 nautilusbiotechnology-st001.jpg GRAPHIC 101923
12 nautilusbiotechnology-st002.jpg GRAPHIC 100050
  Complete submission text file 0001628280-21-011892.txt   1945270
Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 211006636
SIC: 6770 Blank Checks